Cytochrome P450 enzymes (CYPs) are a large superfamily of heme-containing monooxygenase enzymes that are found in animals, plants, and microorganisms. In humans, CYPs are primarily expressed in the liver and are involved in the metabolism of many medications and toxins. The naming of CYPs indicates the gene family, subfamily, and specific gene. Many drugs are metabolized by CYP enzymes in the liver, with CYP1A2, 2C9, 2C19, 2D6, 3A4, and 3A5 responsible for metabolizing around 90% of clinically used drugs. Variants in CYP genes can result in altered drug metabolism among individuals. Drug
Genetic polymorphism in drug transport and drug targets.pavithra vinayak
Genetic polymorphism in drug transport and targets.--pharmacogenetics
DRUG TRANSPORTER
Two types of transporter :
•ATP binding Cassette (ABC) – Found in ABCB, ABCD and ABCG family. Associated with multidrug resistance (MDR) of tumor cells causing treatment failure in cancer.
•Solute Carrier (SLC) – Transport varieties of solute include both charged or uncharged
P-glycoprotein
• ATP binding cassette subfamily B member- 1 (ABCB 1)
• Multidrug resistance protein 1 (MDR1)
• Transport various molecules, including xenobiotic, across cell membrane
• Extensively distributed and expressed throughout the body
Mechanism of Pglycoprotein
Substrate bind to P-gp form the inner leaflet of the membrane
ATP binds at the inner side of the protein
ATP is hydrolyzed to produce ADP and energy
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxAmeena Kadar
Genetic Polymorphism is one of the factors that affects the Drug metabolism. Cytochrome P - 450, one of the prominent group of metabolizing enzymes. In this ppt, genetic polymorphism of cytochrome p 450 is discussed.
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
metabolism of xenobiotis, drugs, medicine, carcinogen generation by enzymes like cyt p450 mono oxigenases, prostaglandin synthase ect. alcohol metabolism, toxin metabolism, definition of genobiotics, biotransformation, detoxification. effects on health
Genetic polymorphism in drug transport and drug targets.pavithra vinayak
Genetic polymorphism in drug transport and targets.--pharmacogenetics
DRUG TRANSPORTER
Two types of transporter :
•ATP binding Cassette (ABC) – Found in ABCB, ABCD and ABCG family. Associated with multidrug resistance (MDR) of tumor cells causing treatment failure in cancer.
•Solute Carrier (SLC) – Transport varieties of solute include both charged or uncharged
P-glycoprotein
• ATP binding cassette subfamily B member- 1 (ABCB 1)
• Multidrug resistance protein 1 (MDR1)
• Transport various molecules, including xenobiotic, across cell membrane
• Extensively distributed and expressed throughout the body
Mechanism of Pglycoprotein
Substrate bind to P-gp form the inner leaflet of the membrane
ATP binds at the inner side of the protein
ATP is hydrolyzed to produce ADP and energy
GENETIC POLYMORPHISM IN DRUG METABOLISM.pptxAmeena Kadar
Genetic Polymorphism is one of the factors that affects the Drug metabolism. Cytochrome P - 450, one of the prominent group of metabolizing enzymes. In this ppt, genetic polymorphism of cytochrome p 450 is discussed.
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
metabolism of xenobiotis, drugs, medicine, carcinogen generation by enzymes like cyt p450 mono oxigenases, prostaglandin synthase ect. alcohol metabolism, toxin metabolism, definition of genobiotics, biotransformation, detoxification. effects on health
Klingbeil, R., 2014. Managed Aquifer Recharge – Aquifer Storage and Recovery: Regional Experiences and Needs for Further Cooperation and Knowledge Exchanges in the Arab Region. Presentation at the Water Science and Technology (WSTA), 11th Gulf Water Conference (GWC), Muscat, Oman, 20-22 Oct 2014.
This is a set of powerpoint slides with self-assessment questions interspersed throuought on drug metabolism and pharmacogenetics. The aim is to understand the mechanism of clinically significant drug interactions, recognize potentially clinically significant genetic influences on drug efficacy and toxicity, and genetic predispositions to disease due to altered drug metabolism or transport. This resource is appropriate for medical students or graduate healthcare professionals such as nursing students.
In this presentation we can see.
What is microbial nutrition and what kind of nutrients take by the microbes, types of nutrients and how microbes uptake nutrients and classification of microorganisms on the basis of nutrition. And Growth factors for microbial growth .What is passive diffusion ,active transport and phagocytosis,
cytochrome p450 is an super family of enzyme that contains a heme as co factor that function as monooxygenase. This enzyme has been identified in all kingdoms of life, like fungi, Protista, bacteria, and as well as in virus.
Chemical conversion of a substance mediated by living organisms or enzymes
Can result in DETOXIFICATION and BIOACTIVATION
Vital to survive
Key in defense mechanism
Polymorphism affecting Drug Metabolism.pptxAnagha R Anil
Genetic polymorphisms can profoundly influence drug metabolism, impacting how medications are processed in the body. Variations in genes encoding drug-metabolizing enzymes, like cytochrome P450 (CYP) enzymes, can lead to differences in drug efficacy and safety among individuals. This presentation provides a concise overview of how polymorphisms affect drug metabolism.
The Root cause and Culprit behind Chronic Diseases, Cancer and Aging is well recognized by many authorities now. 1- A state of chronic low grade inflammation. 2- Mitochondrial dysfunction.
Mitochondria Our body’s lifeline. Mitochondria are tiny organelles in our cell, thousands of them comprising 15 to 50% of the cell volume. Red blood cells and skin cells have very little to none, while germ cells have 100,000, but most cells have one to 2,000 of them. They're the primary source of energy for our body. They supply over 90% of our body’s energy. Converting the food we eat and the air we breathe into usable energy. It have enormous potential to influence our health, specifically cancer, and optimizing mitochondrial metabolism may be at the core of effective cancer treatment.
Introduction to drug metabolism case studies for its impacts on drug discover...SAPA-GP
2014/10/02 SAPA-GP Webinar:
Introduction to drug metabolism case studies for its impacts on drug discovery and development
Zhoupeng Zhang
Dept of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism
Merck Research Laboratories
Sino-American Pharmaceutical Professionals Association (SAPA)
– A lecture for Medicinal Chemists
(October 2, 2014)
Emerging evidence indicates that impaired cellular energy metabolism is the defining characteristic of nearly all cancers regardless of cellular or tissue origin. In contrast to normal cells, which derive most of their usable energy from oxidative phosphorylation, most cancer cells become heavily dependent on substrate level phosphorylation to meet energy demands. Evidence is reviewed supporting a general hypothesis that genomic instability and essentially all hallmarks of cancer, including anaerobic glycolysis (Warburg effect), can be linked to impaired mitochondrial function and energy metabolism. A view of cancer as primarily a metabolic disease and how Autophagy process is activated will impact approaches to cancer management and prevention
2. What Are They?
O Monooxygenase enzymes from the
cytochrome P450 genes
O Humans, plants, animals, prokaryotes
O Humans: ~60 CYP genes
O Arabidopsis: >250 genes
O Arose from gene duplication and
divergence
O Ranging substrate specificity
3. How Are They Named?
O Membrane-bound within a cell (cyto) +
heme pigment (chrome and P) + absorbs
light at 450 nM (450) when exposed to CO
O CYP – cytochrome P450 gene
superfamily
O Number – specific group within the gene
family
O Letter – gene’s subfamily
O Number – specific gene within the
subfamily
O E.g. CYP3A4
4. Where Are They?
O Within the body:
O Throughout
O Primarily in the liver
O Within the cell:
O Endoplasmic reticulum
O Primarily metabolize external substances
(e.g. medications and environmental
pollutants)
O Mitochondria
O Primarily metabolize internal substances
5. What Do They Do?
O Participate in synthesis and metabolism
of molecules and chemicals within cells
O Synthesis: steroid hormones, fats (e.g.
cholesterol, fatty acids) and digestive
acids (e.g. bile acids)
O Metabolism: medications, internal
substances, intracellular toxins
O Essential for normal development,
homeostasis and defense
6. How Do They Work?
O Basic reactions:
O Oxygenation, sulfoxidation, hydroxylation,
reduction, dealkylation, demethylation
epoxide formation, 1,2 migration
O Complex enzymatic reactions:
O Halide (iodine, bromine, chlorine)
oxygenation, aromatic dehalogenation, ring
expansion, ring coupling, etc.
8. How Do They Work?
O Most CYP P450s use a NAD(P)H-driven
redox partner system
O Donate 2 e- to reduce ferric heme
iron and ferrous-oxide species
9. Drug Metabolism
O CYP1A2, 2C9, 2C19, 2D6, 3A4 and 3A5
metabolize 90% of drugs
O Substrate metabolism:
O Activation (e.g. tramadol, losartan)
O Inactivation (e.g. simvastatin)
O Via single enzyme (e.g. metoprolol –
CYP2D6)
O Via multiple enzymes (e.g. warfarin –
CYP1A2, 2D6, 3A4)
10. Cambridge MedChem Consulting (2012). Available at:
http://www.cambridgemedchemconsulting.com/resources/ADME/metabolism.html (accessed 3 May 2016)
11. Pharmacogenetics
O CYP gene = 2 alleles
O Wild-type (wt) most common in general
population
O Variant: usually encode CYP with reduced or
no activity
O Metabolizers:
O 2 wt alleles = “extensive”
O 2 variant alleles = “poor”
O 1 wt + 1 variant = “reduced”
O Multiple wt allele copies = “ultrarapid”
12. Drug Interactions
O CYP inhibitors decrease enzymatic
activity
O Effect is immediate
O Drugs can:
O be a substrate and inhibitor of the same
enzyme (e.g. erythromycin)
O be metabolized by one enzyme and inhibit
another (e.g. terbinafiine)
O be used strategically (e.g. ritonavir added
to decrease lopinavir degradation by
CYP3A4)
13. Drug Interactions
O CYP inducers increase enzyme synthesis
O Effect is delayed
O E.g. decreased substrate concentration
within 24 hours (rifampin) or up to one
week (phenobarbital)
O Drugs can:
O be a substrate and inducer of the same
enzyme (e.g. carbamazepine)
O induce other enzymes
16. Genotype Testing
O Detect CYP450 polymorphisms
O Amplichip CYP450 test
O DNA microarray
O Detect 29 CYP2D6 polymorphisms and 2
CYP2C19 polymorphisms
17. Bacterial P450 Applications
O “The ability of P450s to perform
regioselective and often stereoselective
oxidation of their substrates makes them
attractive catalysts for applications in
synthetic biology and in the generation of
high value oxychemicals that may not be
economical to produce by synthetic
chemistry”
Girvan HM, Munro, AW. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Current Opinion
in Chemical Biology. 2016;31:136-146.
18. Bacterial P450 Models
O Protein engineering, rational
mutagenesis, etc.
O Ex: P450 BM3 (fusion protein with high
catalytic rate)
O Omeprazole – increased active site space
and conformational change drug
oxidation mimicking human CYP2C19
O Diclofenac metabolism
O 17-beta-estradiol
19. Girvan HM, Munro, AW. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Current Opinion
in Chemical Biology. 2016;31:136-146.
20. References
Cytochrome p450. NIG U.S. National Library of Medicine. Available at:
https://ghr.nlm.nih.gov/primer/genefamily/cytochromep450 (Accessed 3 May
2016)
Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th edition. New York: W H
Freeman; 2002. Section 26.4, Important Derivatives of Cholesterol Include Bile
Salts and Steroid Hormones. Available from:
http://www.ncbi.nlm.nih.gov/books/NBK22339/
Isin EM, Guengerich FP. Complex reactions catalyzed by cytochrome P450
enzymes. Biochimica et Biophysica Acta. 2007;1770(3):314-329
Lynch T, Price A. The Effect of Cytochrome P450 Metabolism on Drug Response,
Interactions, and Adverse Effects. American Academy of Family Physicians
2007;76(3):391-396
Girvan HM, Munro, AW. Applications of microbial cytochrome P450 enzymes in
biotechnology and synthetic biology. Current Opinion in Chemical Biology.
2016;31:136-146.
Cambridge MedChem Consulting (2012). Available at: http://www.cambridgemedchemconsulting.com/resources/ADME/metabolism.html (accessed 3 May 2016)
Girvan HM, Munro, AW. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Current Opinion in Chemical Biology. 2016;31:136-146.
Girvan HM, Munro, AW. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Current Opinion in Chemical Biology. 2016;31:136-146.
Girvan HM, Munro, AW. Applications of microbial cytochrome P450 enzymes in biotechnology and synthetic biology. Current Opinion in Chemical Biology. 2016;31:136-146.